Brought to you by 
PhotoThera gets $50mm through its Series D round
16 Jun 2009
Executive Summary
PhotoThera (stroke therapy) has raised $50mm through the closing of its Series D venture round. Warburg Pincus led the financing and was joined by fellow existing backers Vertical Group, Hamilton BioVentures, Delphi Ventures, DeNovo Ventures, Solstice Capital, and members of Monterey Advisors. PhotoThera will use the proceeds to fund a redesigned Phase III trial of NeuroThera--an infrared laser to noninvasively treat ischemic stroke--because its last study did not meet primary endpoints. The company has brought in over $100mm to date.
Deal Industry
- Medical Devices
-
Medical Devices
- Laser
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PhotoThera gets $50mm through its Series D round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice